3 results
Approved WMOCompleted
This non-controlled multicentric phase II study is designed to assess the safety and to describe (in relation to children of higher age) the pharmacodynamics of recombinant ASNase for first-line treatment of infants (< 1 year of age at…
Approved WMOPending
To assess long-term outcomes in low-immunological risk renal transplant patients beyond one year after transplantation using tacrolimus monotherapy versus tacrolimus with mycophenolate mofetil.
Approved WMOCompleted
This multicentre phase III study is designed to assess the efficacy and safety of recombinant versus E-Coli derived Aaparaginase from Medac, during treatment of children with newly diagnosed ALL according to the DCOG ALL-10 protocol.Futhermore: To…